行情

AXDX

AXDX

Accelr科技
NASDAQ

实时行情|Nasdaq Last Sale

21.39
0.00
0.00%
交易中 11:52 09/23 EDT
开盘
21.23
昨收
21.39
最高
21.39
最低
21.00
成交量
2.11万
成交额
--
52周最高
24.00
52周最低
10.23
市值
11.66亿
市盈率(TTM)
-13.3738
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AXDX 新闻

  • 投资银行派杰:美国消费者对新iPhone的兴趣不及去年
  • 新浪美股.35分钟前
  • 美国9月Markit制造业和服务业PMI初值好坏参半
  • 汇通网.1小时前
  • 沙特复产需要两周还是十个月?油市最大谜团将揭晓
  • 新浪财经综合.1小时前
  • 摩根大通称美联储可能需要帮助恢复资金市场的平衡
  • 新浪美股.1小时前

更多

所属板块

先进医疗设备和技术
-2.02%
医疗设备和用品
-0.84%

热门股票

名称
价格
涨跌幅

AXDX 简况

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
展开

Webull提供Accelerate Diagnostics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。